Parvovirus B19 Persistence in Abnormal Thyroid Tissue of a Mature Cystic Ovarian Teratoma: A Case Report

Endocrine Pathology

Volumn 25, Issue 3, 2014, Pages 339-343

  Adamson Small, Laura A ^a   Fowler, Larry J ^a,b   Hobbs, Jacqueline A ^a  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^b NONE   (United States)

Author keywords

Cystic teratoma; Ovary; Parvovirus B19; Thyroid

Indexed keywords

CAPSID PROTEIN;

CASE REPORT; FEMALE; HUMAN; HUMAN PARVOVIRUS B19; ISOLATION AND PURIFICATION; METABOLISM; MIDDLE AGED; OVARY TUMOR; PATHOLOGY; TERATOMA; THYROID GLAND; VIROLOGY;

CAPSID PROTEINS; FEMALE; HUMANS; MIDDLE AGED; OVARIAN NEOPLASMS; PARVOVIRUS B19, HUMAN; TERATOMA; THYROID GLAND;

EID: 84896550164     PISSN: 10463976     EISSN: 15590097     Source Type: Journal    
DOI: 10.1007/s12022-014-9305-z     Document Type: Article

References (31)

1. Makani S, Kim W, Gaba AR. Struma Ovarii with a focus of papillary thyroid cancer: a case report and review of the literature. Gynecol Oncol 94: 835-839, 2004.
2. Surti U, Hoffner L, Chakravarti A, Ferrell R. Genetics and biology of human ovarian teratomas. I. Cytogenetic analysis and mechanism of origin. Am J Hum Genet 47: 635, 1990.
3. Hackethal A, Brueggmann D, Bohlmann MK, Franke FE, Tinneberg HR, Munstedt K. Squamous-cell carcinoma in mature cystic teratoma of the ovary: systematic review and analysis of published data. The Lancet Oncology 9: 1173-1180, 2008.
4. Outwater EK, Siegelman ES, Hunt JL. Ovarian Teratomas: Tumor Types and Imaging Characteristics1. Radiographics 21: 475-490, 2001.
5. Matsuda K, Maehama T, Kanazawa K. Malignant struma ovarii with thyrotoxicosis. Gynecol Oncol 82: 575-577, 2001.
6. Desailloud R, Hober D. Viruses and thyroiditis: an update. Virol J 6: 5, 2009.
7. Adamson LA, Fowler LJ, Ewald AS, Clare–Salzler MJ, Hobbs JA. Infection and persistence of erythrovirus B19 in benign and cancerous thyroid tissues. J Med Virol, 2013.
8. Wang JH, Zhang WP, Liu HX, Wang D, Li YF, Wang WQ, Wang L, He FR, Wang Z, Yan QG, Chen LW, Huang GS. Detection of human parvovirus B19 in papillary thyroid carcinoma. Br J Cancer 98: 611-618, 2008.
9. Wang JH, Zhang WP, Liu HX, Wang D, Wang W, Li YF, Wang L, Zhang W, Huang G. Parvovirus B19 infection associated with Hashimoto’s thyroiditis in adults. J Infect 60: 360-370, 2010.
10. Young NS, Brown KE. Parvovirus B19. NEJM 350: 586-597, 2004.
11. Polcz ME, Adamson LA, Datar RS, Fowler LJ, Hobbs JA. Detection of parvovirus B19 capsid proteins in testicular tissues. Urology 79: 744.e749-715, 2012.
12. Norja P, Hokynar K, Aaltonen LM, Chen R, Ranki A, Partio EK, Kiviluoto O, Davidkin I, Leivo T, Eis-Hübinger AM, Schneider B, Fischer HP, Tolba R, Vapalahti O, Vaheri A, Söderlund-Venermo M, Hedman K. Bioportfolio: lifelong persistence of variant and prototypic erythrovirus DNA genomes in human tissue. PNAS 103: 7450-7453, 2006.
13. Lehmann HW, Lutterbüse N, Plentz A, Akkurt I, Albers N, Hauffa BP, Hiort O, Schoenau E, Modrow S. Association of parvovirus B19 infection and Hashimoto’s thyroiditis in children. Viral Immunal 21: 379-384, 2008.
14. Page C, Hoffmann TW, Benzerdjeb N, Duverlie G, Sevestre H, Desailloud R. Detection of erythrovirus B19 in thyroidectomy specimens from graves’ disease patients: A case–control study. J Med Virol 85: 1414-1419, 2013.
15. Bergallo M, Costa C, Sidoti F, Novelli M, Ponti R, Castagnoli C, Merlino C, Bernengo MG, Cavallo R. Variants of Parvovirus B19: Bioinformatical Evaluation of Nested PCR Assays. Intervirology 51: 75-80, 2008.
16. Liu LC, Huang RL, Lin YC, Lai HC, Su HY, Chang FW, Yu MH. Squamous cell carcinoma arising from an ovarian teratoma related to human papillomavirus infection: using a PCR-based reverse-blot assay. Taiwan J Obstet Gynecol 50: 543-545, 2011.
17. Mai KT, Yazdi HM, Bertrand MA, LeSaux N, Cathcart L. Bilateral primary ovarian squamous cell carcinoma associated with human papilloma virus infection and vulvar and cervical intraepithelial neoplasia: a case report with review of the literature. The Am J Surg Pathol 20: 767-772, 1996.
18. Pins MR, Young RH, Crum CP, Leach IH, Scully RE. Cervical squamous cell carcinoma in situ with intraepithelial extension to the upper genital tract and invasion of tubes and ovaries: report of a case with human papilloma virus analysis. Int J Gynecol Pathol 16: 272-278, 1997.
19. Verguts J, Amant F, Moerman P, Vergote I. HPV induced ovarian squamous cell carcinoma: case report and review of the literature. Arch Gynecol Obstet 276: 285-289, 2007.
20. Manolitsas TP, Lanham SA, Hitchcock A, Watson RH. Synchronous ovarian and cervical squamous intraepithelial neoplasia: an analysis of HPV status. Gynecol Oncol 70: 428-431, 1998.
21. Bell MC, Schmidt-Grimminger DC, Connor MG, Alvarez RD. A cervical teratoma with invasive squamous cell carcinoma in an HIV-infected patient: a case report. Gynecol Oncol 60: 475-479, 1996.
22. Thatigotla B, Vattipally V, Khaneja SC, Cosgrove JM. Malignant transformation of an anterior mediastinal dermoid cyst in an HIV patient. Am Surg 76: E92-93, 2010.
23. Woods GL, Walker DH. Detection of infection or infectious agents by use of cytologic and histologic stains. Clin Microbiol Rev 9: 382-404, 1996.
24. Gray A, Guillou L, Zufferey J, Rey F, Kurt AM, Jichlinkski P, Leisinger HJ, Benhattar J. Persistence of parvovirus B19 DNA in testis of patients with testicular germ cell tumours. J Gen Virol 79: 573-579, 1998.
25. Diss TC, Pan LX, Du MQ, Peng HZ, Kerr JR. Parvovirus B19 is associated with benign testes as well as testicular germ cell tumours. Mol Path 52: 349-352, 1999.
26. Ergunay K, Tezel GG, Dogan AI, Ozen H, Sirin G, Ozbay M, Karabulut E, Ustacelei S. Testicular persistence of Parvovirus B19: Evidence for preferential infection of germ cell tumors. Pathol Res Pract 204: 649-53, 2008.
27. Hinshaw HD, Smith AL, Desouki MM, Olawaiye AB. Malignant transformation of a mature cystic ovarian teratoma into thyroid carcinoma, mucinous adenocarcinoma, and strumal carcinoid: a case report and literature review. Case Rep Obstet Gynecol 2012: 269489, 2012.
28. Mori K, Munakata Y, Saito T, Tani J, Nakagawa Y, Hoshikawa S, Ozaki H, Ito S, Yoshida K. Intrathyroidal persistence of human parvovirus B19 DNA in a patient with Hashimoto’s thyroiditis. J Infect 55: e29-e31, 2007.
29. Polcz ME, Adamson LA, Lu X, Chang MN, Fowler LJ, Hobbs JA. Increased IL-6 detection in adult and pediatric lymphoid tissue harboring parvovirus B19. J Clin Virol 57: 233-238, 2013.
30. Takahashi Y, Murai C, Shibata S, Munakata Y, Ishii T, Ishii K, Saitoh T, Sawai T, Sugamura K, Sasaki T. Human parvovirus B19 as a causative agent for rheumatoid arthritis. PNAS 95: 8227-8232, 1998.
31. Cioc AM, Sedmak DD, Nuovo GJ, Dawood MR, Smart G, Magro CM. Parvovirus B19 associated adult Henoch Schonlein purpura. J Cutan Pathol 29: 602-607, 2002.